Patents by Inventor Vikram Natwarsinhji SISODIYA

Vikram Natwarsinhji SISODIYA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL ANTI-CLAUDIN ANTIBODIES AND METHODS OF USE
    Publication number: 20190083645
    Abstract: Provided herein are novel anti-CLDN antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
    Type: Application
    Filed: December 2, 2016
    Publication date: March 21, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: SARAH FONG, VIKRAM NATWARSINHJI SISODIYA, ROBERT A. STULL, SAMUEL A. WILLIAMS
  • SITE-SPECIFIC ANTIBODY CONJUGATION METHODS AND COMPOSITIONS
    Publication number: 20180346565
    Abstract: Provided are novel antibody drug conjugates (ADCs), and methods of using such ADCs to treat proliferative disorders.
    Type: Application
    Filed: July 30, 2018
    Publication date: December 6, 2018
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: WILLIAM ROBERT ARATHOON, ISHAI PADAWER, LUIS ANTONIO CANO, VIKRAM NATWARSINHJI SISODIYA, KARTHIK NARAYAN MANI, DAVID LIU
  • Site-specific antibody conjugation methods and compositions
    Patent number: 10035853
    Abstract: Provided are novel antibody drug conjugates (ADCs), and methods of using such ADCs to treat proliferative disorders.
    Type: Grant
    Filed: February 29, 2016
    Date of Patent: July 31, 2018
    Assignee: AbbVie Stemcentrx LLC
    Inventors: William Robert Arathoon, Ishai Padawer, Luis Antonio Cano, Vikram Natwarsinhji Sisodiya, Karthik Narayan Mani, David Liu
  • CALICHEAMICIN CONSTRUCTS AND METHODS OF USE
    Publication number: 20180133337
    Abstract: Provided herein are antibody drug conjugates (ADCs) comprising calicheamicin and methods of using the same to treat proliferative disorders.
    Type: Application
    Filed: April 21, 2016
    Publication date: May 17, 2018
    Inventors: Julia Gavrilyuk, Vikram Natwarsinhji Sisodiya
  • ENGINEERED SITE-SPECIFIC ANTIBODIES AND METHODS OF USE
    Publication number: 20180112004
    Abstract: Provided are novel antibody drug conjugates (ADCs), and methods of using such ADCs to treat proliferative disorders.
    Type: Application
    Filed: March 4, 2016
    Publication date: April 26, 2018
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: DAVID LIU, VIKRAM NATWARSINHJI SISODIYA, JOSEPH LEUNG
  • ENGINEERED ANTI-DLL3 CONJUGATES AND METHODS OF USE
    Publication number: 20160175460
    Abstract: Provided are novel antibody drug conjugates (ADCs), and methods of using such ADCs to treat proliferative disorders.
    Type: Application
    Filed: February 29, 2016
    Publication date: June 23, 2016
    Applicant: Stemcentrx, Inc.
    Inventors: William Robert ARATHOON, Ishai PADAWER, Luis Antonio CANO, Vikram Natwarsinhji SISODIYA, Karthik Narayan MANI, David LIU
  • SITE-SPECIFIC ANTIBODY CONJUGATION METHODS AND COMPOSITIONS
    Publication number: 20160176964
    Abstract: Provided are novel antibody drug conjugates (ADCs), and methods of using such ADCs to treat proliferative disorders.
    Type: Application
    Filed: February 29, 2016
    Publication date: June 23, 2016
    Inventors: William Robert Arathoon, Ishai Padawer, Luis Antonio Cano, Vikram Natwarsinhji Sisodiya, Karthik Narayan Mani, David Liu